Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
Pilot Study on the Contribution of Molecular Analysis of Endometrial Cancers: Reliability, and Interest of Circulating Tumor DNA
Sponsor: Poitiers University Hospital
A NA clinical study on Circulating Tumor DNA and Endometrial Cancer, this trial is completed. The trial is conducted by Poitiers University Hospital and has accumulated 6 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Apr 2022 — Feb 2023 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2022 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Poitiers University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Poitiers, France